Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis and consumer packaged goods (CPG) company. The Company delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space. Its CPG portfolio includes gourmet wellness products by Martha Stewart CBD, and vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution, and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a diverse range of cannabis, hemp, and cannabis products in Canada. Its Rest-of-world cannabis segment includes the production, distribution, and sale of a diverse range of cannabis and hemp products internationally. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers.


TSX:WEED - Post by User

Bullboard Posts
Comment by Singidunumon Jun 21, 2019 11:20pm
41 Views
Post# 29851949

RE:RE:RE:Revenue growth too slow..needs US expansion

RE:RE:RE:Revenue growth too slow..needs US expansionKing Kong is old HIVE bagholder Mackie. Ignore this loser. He lost money on every stock he bought. He is a loser and a bigot. Ignore his posts. He is a moron. He bought HIVE at $5 and WEEd at $65. He is a sick puppy who should be on mediaction. He doesnt know anything about cannabis stosck or blockchain. He is a moron who loses money on every  investment. Poor soul. 

KingKong wrote: 5 year percentage gains of some publicly traded Marijuna companies. 

Canopy +1722%

Cronos +3087%

Aphria +755%

Hexo +882%

OGI +408%

Tinley Beverages in 3 & a half years +900%

If you had to own one for the next 5 years who would it be?

If a company is missing with better percentage gains simply say them instead with % gains attatched. I pick Tinley Beverages because of their California, Nevada & NY expansion priorities, THC/CBD infused beverages pioneers with an innovative approach, plus A1 management from Coca Cola, Cott, Constellation Brands.

glta


Bullchart1 wrote: Canopy will get there. Patience. Have a look at some of the comments 1 year and 2 years ago. Same old bashing. Show me another company sitting on the uptrend at 52.00 over the past 2 years. Possible pullback to 45.00 but that will be short lived.

Anyone that thinks Canopy will drop over the next couple months, put your money where your mouth is. Buy PUTS with Aug expiry. Stockastics is very low here to be too bearish so I will hold a solid position here and add on weakness.

Keep in mind another 4.5 BILLION will be injected later this year from Constellation. Many have forgotton about that. 


Waterboy45 wrote: Huge market cap but unable to quickly growth sales atb a scalar level.

A large part of the problem is Canopys concentration in Canada, rather than the US where the cannabis market is 12 times greater.

In addition, the canadian market was launched before the vertical chains needed to produce and get the product to consumers , were in place.

Still, with $4.5 b in cash it can quickly expand to the US market by acquisition.

To do so, it needs to acquire producing microcaps which are vertically integrated with substantial revenues and strong growth profile.


That is it will  have to acquire dispensaries which are MSO ( Multi  State  ) have assocoiated vertically integrated assets, such as  delivery licences, e commerce platform, distribution licences, as well as THC extraction facilities and nutritional facilities .

I know of only one cannabis company that can fulfill all of these requiremens as well as cultivation facilities in Washington.

Its Captor ( CPTR $1.25 /39 m shares )

Captor will do   $90 m US  in sales this fiscal year.......rising to over $200 m in 2020 from its acquisition of 30 licences ( 20 of whiach are dispensaries )  from Green Buddha which will make it fully MSO.



 What I  has been described for Captor is real and can be viewed at their recent summary presentation...........

https://captorcapital.com/wp-content/uploads/2019/05/Captor-Capital-Corp-Shareholder-Presentation-May-14-2019.pdf

No other cannabis stock offers such comprehensive assets at such a low market cap, and also over $50 m in cash

 




Bullboard Posts